The presence of two distinct subclusters of DCs in chordoma lesions, namely, CLEC9A DCs and activated DCs (Figure 3B), underscores their crucial role as major contributors to the immune response against cancerous growth. This evidence concerns the gene CLEC9A and chordoma.